Viewpoint
Preparing for Year Two of Pay versus Performance Disclosures
Mike Kesner, Ed Sim, and Ben Stradley
Viewpoint
Issues Facing Compensation Committees in 2024
Mike Kesner, Steve Pakela, and Lane Ringlee
Viewpoint
Biotech Industry Trends in Equity Compensation: Influence of Market Volatility on Equity Program Strategy
Michael Keebaugh, Brian Lane, and Ryan Peterson
Viewpoint
The 2023 Say on Pay Season – Outcomes and Observations
Perla Cuevas, Jose Lawani, Joe Mallin and Linda Pappas